{"id":14152,"date":"2022-03-28T17:07:26","date_gmt":"2022-03-28T17:07:26","guid":{"rendered":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows"},"modified":"2022-03-28T19:28:42","modified_gmt":"2022-03-28T19:28:42","slug":"sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","title":{"rendered":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows"},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Rwanda. <\/strong><\/span>According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of the infection. The Russian Direct Investment Fund (RDIF), which invested in Sputnik&#8217;s V development, points out that vaccination with the Russian jab is now the &#8220;ultimate solution&#8221; for HIV-positive people.<\/p>\n<p>The world&#8217;s first registered COVID-19 vaccine, Sputnik V, has now become the first jab to provide proven protection against the coronavirus for HIV-positive individuals, a new study, conducted jointly by the vaccine developer &#8211; the Gamaleya Research Centre of Epidemiology &#8211; and the Moscow City Centre for AIDS Prevention and Control, shows.<\/p>\n<p>According to the study, published in the international medical journal The Lancet, Sputnik V retained 79% efficacy against COVID-19 in people with HIV receiving antiretroviral therapy (ART). The research is based on a retrospective cohort study conducted using data on 24,000 HIV patients.<\/p>\n<p>The vaccine also showed 90% efficacy in preventing hospitalisations with COVID-19 for these patients and it was 97% effective against the development of moderate or severe illness caused by the coronavirus in those with HIV.<\/p>\n<p>The study specified that HIV patients on ART with relatively high counts of T helper cells, which play an important role in detecting pathogens and adapting immune system response to them, received better protection from Sputnik V. Patients with T helper cell levels in blood above 350\/\u00b5l experienced a 3.3-fold reduction of COVID-19 infections. Those with levels below 350\/\u00b5l had their risk of suffering from COVID-19 reduced by 2.5 times, the study said. Counts below 200 are generally considered acquired immune deficiency syndrome (AIDS).<\/p>\n<p>The World Health Organisation&#8217;s data suggests that 23% HIV-positive patients hospitalised with COVID-19 died from the disease, making them one of the most vulnerable groups in this pandemic.<\/p>\n<p>Sputnik V was registered in August 2020 becoming the world&#8217;s first COVID-19 vaccine with a proven efficacy of 97.6%. With the help of the RDIF, the vaccine was registered in 71 countries and exported globally. The two-shot jab also proved to be effective against all variants of the coronavirus, providing lasting protection against them. The Gamaleya Research Centre later released a one-shot variant of the vaccine, Sputnik Light, which can also serve as a booster jab for recipients of not only Sputnik V, but other vaccines as well, including foreign medications \u2013 such as the Astra-Zeneca vaccine.<\/p>\n<p><strong>For More News And Analysis About <a href=\"https:\/\/www.africa-press.net\/rwanda\">Rwanda<\/a> Follow <a href=\"https:\/\/www.africa-press.net\/\">Africa-Press<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Rwanda. According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of the infection. The Russian Direct Investment Fund (RDIF), which invested in Sputnik&#8217;s V development, points out that vaccination with the Russian jab is now the &#8220;ultimate solution&#8221; for HIV-positive people. The world&#8217;s first [&hellip;]<\/p>\n","protected":false},"author":84,"featured_media":14151,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24,28,31],"tags":[760,763,758],"class_list":["post-14152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-news","category-homepage-english","category-miscellaneous","tag-africa-press","tag-africa-press-rwanda","tag-rwanda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows - Rwanda<\/title>\n<meta name=\"description\" content=\"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows\" \/>\n<meta property=\"og:description\" content=\"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\" \/>\n<meta property=\"og:site_name\" content=\"Rwanda\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-28T17:07:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-28T19:28:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditoren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditoren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\"},\"author\":{\"name\":\"cfeditoren\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"headline\":\"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows\",\"datePublished\":\"2022-03-28T17:07:26+00:00\",\"dateModified\":\"2022-03-28T19:28:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\"},\"wordCount\":405,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg\",\"keywords\":[\"Africa Press\",\"Africa Press-Rwanda\",\"Rwanda\"],\"articleSection\":[\"all news\",\"homepage-english\",\"Miscellaneous\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\",\"url\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\",\"name\":\"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows - Rwanda\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg\",\"datePublished\":\"2022-03-28T17:07:26+00:00\",\"dateModified\":\"2022-03-28T19:28:42+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"description\":\"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.africa-press.net\/rwanda\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#website\",\"url\":\"https:\/\/www.africa-press.net\/rwanda\/\",\"name\":\"Rwanda\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/rwanda\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\",\"name\":\"cfeditoren\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows - Rwanda","description":"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","og_locale":"en_US","og_type":"article","og_title":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows","og_description":"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...","og_url":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","og_site_name":"Rwanda","article_published_time":"2022-03-28T17:07:26+00:00","article_modified_time":"2022-03-28T19:28:42+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg","type":"image\/jpeg"}],"author":"cfeditoren","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cfeditoren","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows"},"author":{"name":"cfeditoren","@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"headline":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows","datePublished":"2022-03-28T17:07:26+00:00","dateModified":"2022-03-28T19:28:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows"},"wordCount":405,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg","keywords":["Africa Press","Africa Press-Rwanda","Rwanda"],"articleSection":["all news","homepage-english","Miscellaneous"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","url":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows","name":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows - Rwanda","isPartOf":{"@id":"https:\/\/www.africa-press.net\/rwanda\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg","datePublished":"2022-03-28T17:07:26+00:00","dateModified":"2022-03-28T19:28:42+00:00","author":{"@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"description":"According to data from the World Health Organisation, 23% of patients with HIV who contracted the coronavirus died of th ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#primaryimage","url":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg","contentUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2022\/03\/img-62420c28eef3a.jpg","width":1920,"height":1080,"caption":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/rwanda\/all-news\/sputnik-v-vaccine-maintains-79-efficacy-in-hiv-patients-on-antiretroviral-therapy-study-shows#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.africa-press.net\/rwanda\/"},{"@type":"ListItem","position":2,"name":"Sputnik V Vaccine Maintains 79% Efficacy in HIV Patients on Antiretroviral Therapy, Study Shows"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/rwanda\/#website","url":"https:\/\/www.africa-press.net\/rwanda\/","name":"Rwanda","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/rwanda\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb","name":"cfeditoren"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts\/14152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/users\/84"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/comments?post=14152"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts\/14152\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/media\/14151"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/media?parent=14152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/categories?post=14152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/tags?post=14152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}